Clinical Outsourcing Strategies and Operations 5th Annual Conference
COS 2017 (Clinical Outsourcing Strategies 2017) been in motion as an annual event for the past five years serving as a platform for premier CROs involved in clinical trials within the pharmaceutical segment. The 5th annual COS symposium has been designed to engage a more ‘bow tie’ communication approach so to create an agreeable environment for Sponsors-& CROs/Vendors. The process is Omni-encompassing of all processes and stakeholders from partner selection to after-contract obligations. While COS is strategically focused on creating an atmosphere of optimization based on Transparency and Accountability when engaging the Clinical Trial Outsourcing Journey.
For 2017 speaking panel includes a variety of Bio/Pharma companies, such as Sanofi, Novartis, Janssen Biologics and many more.
One of our partners that will be exhibiting at the COS 2017 Conference is Cato Research, the international, full-service CRO with offices across North America, Europe, Israel and South Africa. Their multidisciplinary approach to drug development and our highly experienced professionals have successfully contributed to numerous development programs leading to marketing approvals in Europe and the US throughout the past 30 years.
Cato Research broad spectrum of services includes regulatory affairs, management and monitoring of clinical trials, oversight management, as well as medical and pharmacovigilance. The company a proven track record in successfully managing translational medicine, complex phase 1 and 2, as well as orphan drug indication programs.
Cato’s added-value is based on a combination of quality people, quality data and quality service guaranteeing operational and service excellence.
For more information about the Conference Agenda, Participants List and Exhibition Opportunities, visit our website http://www.clinical-outsourcing.com/exhibition.html or contact us: email@example.com
+44 (0) 207 096 1152